We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

Leerink analyst warned that Moderna (NASDAQ:MRNA) shares could fall more than 30% if interim results from its Phase 3 CMV ...

Edwin Stone, Bernard Sagaert, and Khaled Yamout go behind the headlines to discuss what the ongoing measles outbreak in the ...

The central dogma of biology defines the flow of genetic information: It describes how proteins are made from mRNA templates, ...

Australia’s first ever mRNA vaccine manufacturing facility is now operational in Melbourne, with locally made Moderna jabs ...

Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds ...

Sunshine Biopharma (SBFM) has completed mouse model studies providing proof-of-concept for the Company’s K1.1 mRNA product as a novel ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Advantage Therapeutics is spinning off some of its age-related disease R&D into a new company called Klothea Bio. | Klothea ...

A preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness ...

撰文丨王聪编辑丨王多鱼排版丨水成文众所周知，根据中心法则，DNA转录为mRNA，mRNA再翻译为蛋白质，mRNA的降解速率是每个基因产生的蛋白质的数量的主要决定因素，而这又会影响细胞功能。例如，对于mRNA疫苗，mRNA存在更长时间会产生更多蛋白质， ...